{
  "fullName": "Aparna Hegde",
  "slug": "aparna-hegde",
  "title": "MD",
  "specialty": "Pediatric neurosurgery",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 23.14,
  "hIndex": 19,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Aparna Balamurali is an Indian actress and playback singer, who primarily works in Malayalam and Tamil films. She is the recipient of a National Film Award and a Filmfare Award South. Aparna is known for her roles in the films Maheshinte Prathikaaram (2016), Sunday Holiday (2017), Soorarai Pottru (2020), and Kishkindha Kaandam (2024), winning the National Film Award for Best Actress for Soorarai Pottru. In 2025, Aparna was placed by Forbes Asia in their 30 Under 30 list.",
  "aiSummary": "Aparna Hegde is a pediatric neurosurgery specialist with an H-index of 19 at Neurosurgery (Member). Has been published in New England Journal of Medicine, Nature Reviews Clinical Oncology, JAMA. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Neurosurgery"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Neurosurgery",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Pediatric neurosurgery"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2022,
      "citationCount": 1369,
      "doi": "10.6004/jnccn.2022.0025",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2022.0025",
      "verified": true
    },
    {
      "title": "NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2021,
      "citationCount": 989,
      "doi": "10.6004/jnccn.2021.0013",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2021.0013",
      "verified": true
    },
    {
      "title": "Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma",
      "journal": "New England Journal of Medicine",
      "year": 2023,
      "citationCount": 731,
      "doi": "10.1056/nejmoa2211437",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2211437",
      "verified": true
    },
    {
      "title": "NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2023,
      "citationCount": 443,
      "doi": "10.6004/jnccn.2023.0020",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2023.0020",
      "verified": true
    },
    {
      "title": "Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2022,
      "citationCount": 395,
      "doi": "10.6004/jnccn.2022.0020",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2022.0020",
      "verified": true
    },
    {
      "title": "Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade",
      "journal": "Journal of Oncology Pharmacy Practice",
      "year": 2017,
      "citationCount": 315,
      "doi": "10.1177/1078155217745144",
      "sourceUrl": "https://doi.org/10.1177/1078155217745144",
      "verified": true
    },
    {
      "title": "The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases",
      "journal": "Blood",
      "year": 2016,
      "citationCount": 221,
      "doi": "10.1182/blood-2015-09-672030",
      "sourceUrl": "https://doi.org/10.1182/blood-2015-09-672030",
      "verified": true
    },
    {
      "title": "COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials",
      "journal": "Nature Reviews Clinical Oncology",
      "year": 2021,
      "citationCount": 139,
      "doi": "10.1038/s41571-021-00487-z",
      "sourceUrl": "https://doi.org/10.1038/s41571-021-00487-z",
      "verified": true
    },
    {
      "title": "Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies",
      "journal": "ESMO Open",
      "year": 2020,
      "citationCount": 58,
      "doi": "10.1136/esmoopen-2020-000799",
      "sourceUrl": "https://doi.org/10.1136/esmoopen-2020-000799",
      "verified": true
    },
    {
      "title": "A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies",
      "journal": "Clinical Cancer Research",
      "year": 2021,
      "citationCount": 58,
      "doi": "10.1158/1078-0432.ccr-20-4118",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-20-4118",
      "verified": true
    },
    {
      "title": "ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).",
      "journal": "Journal of Clinical Oncology",
      "year": 2022,
      "citationCount": 56,
      "doi": "10.1200/jco.2022.40.36_suppl.397600",
      "sourceUrl": "https://doi.org/10.1200/jco.2022.40.36_suppl.397600",
      "verified": true
    },
    {
      "title": "Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?",
      "journal": "Bone Marrow Transplantation",
      "year": 2017,
      "citationCount": 45,
      "doi": "10.1038/bmt.2017.192",
      "sourceUrl": "https://doi.org/10.1038/bmt.2017.192",
      "verified": true
    },
    {
      "title": "Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database",
      "journal": "Acta Oncologica",
      "year": 2017,
      "citationCount": 36,
      "doi": "10.1080/0284186x.2017.1415460",
      "sourceUrl": "https://doi.org/10.1080/0284186x.2017.1415460",
      "verified": true
    },
    {
      "title": "High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers",
      "journal": "Fertility and Sterility",
      "year": 2012,
      "citationCount": 34,
      "doi": "10.1016/j.fertnstert.2012.06.006",
      "sourceUrl": "https://doi.org/10.1016/j.fertnstert.2012.06.006",
      "verified": true
    },
    {
      "title": "Change in Reporting of USMLE Step 1 Scores and Potential Implications for International Medical Graduates",
      "journal": "JAMA",
      "year": 2020,
      "citationCount": 29,
      "doi": "10.1001/jama.2020.2956",
      "sourceUrl": "https://doi.org/10.1001/jama.2020.2956",
      "verified": true
    },
    {
      "title": "A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6–Targeting Antibody–Drug Conjugate, in Patients with Small Cell Lung Cancer",
      "journal": "Clinical Cancer Research",
      "year": 2024,
      "citationCount": 25,
      "doi": "10.1158/1078-0432.ccr-24-1547",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-24-1547",
      "verified": true
    },
    {
      "title": "Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2023,
      "citationCount": 24,
      "doi": "10.6004/jnccn.2023.0045",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2023.0045",
      "verified": true
    },
    {
      "title": "Safety, efficacy, and on-treatment circulating tumor DNA (ctDNA) changes from a phase 1 study of RMC-6236, a RAS(ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC).",
      "journal": "Journal of Clinical Oncology",
      "year": 2025,
      "citationCount": 24,
      "doi": "10.1200/jco.2025.43.4_suppl.722",
      "sourceUrl": "https://doi.org/10.1200/jco.2025.43.4_suppl.722",
      "verified": true
    },
    {
      "title": "Antibiotic use and overall survival in lung cancer patients receiving nivolumab.",
      "journal": "Journal of Clinical Oncology",
      "year": 2018,
      "citationCount": 22,
      "doi": "10.1200/jco.2018.36.15_suppl.e15109",
      "sourceUrl": "https://doi.org/10.1200/jco.2018.36.15_suppl.e15109",
      "verified": true
    },
    {
      "title": "Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After",
      "journal": "Frontiers in Oncology",
      "year": 2022,
      "citationCount": 19,
      "doi": "10.3389/fonc.2022.785350",
      "sourceUrl": "https://doi.org/10.3389/fonc.2022.785350",
      "verified": true
    },
    {
      "title": "Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy",
      "journal": "Journal for ImmunoTherapy of Cancer",
      "year": 2024,
      "citationCount": 19,
      "doi": "10.1136/jitc-2023-007675",
      "sourceUrl": "https://doi.org/10.1136/jitc-2023-007675",
      "verified": true
    },
    {
      "title": "First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in patients with small cell lung cancer.",
      "journal": "Journal of Clinical Oncology",
      "year": 2023,
      "citationCount": 17,
      "doi": "10.1200/jco.2023.41.16_suppl.3002",
      "sourceUrl": "https://doi.org/10.1200/jco.2023.41.16_suppl.3002",
      "verified": true
    },
    {
      "title": "LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801",
      "journal": "Annals of Oncology",
      "year": 2023,
      "citationCount": 14,
      "doi": "10.1016/j.annonc.2023.10.042",
      "sourceUrl": "https://doi.org/10.1016/j.annonc.2023.10.042",
      "verified": true
    },
    {
      "title": "Activity of Brigatinib in Crizotinib and Ceritinib-Resistant <i>ROS1-</i> Rearranged Non–Small-Cell Lung Cancer",
      "journal": "JCO Precision Oncology",
      "year": 2019,
      "citationCount": 11,
      "doi": "10.1200/po.18.00267",
      "sourceUrl": "https://doi.org/10.1200/po.18.00267",
      "verified": true
    },
    {
      "title": "Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma",
      "journal": "ESMO Open",
      "year": 2021,
      "citationCount": 11,
      "doi": "10.1016/j.esmoop.2021.100172",
      "sourceUrl": "https://doi.org/10.1016/j.esmoop.2021.100172",
      "verified": true
    },
    {
      "title": "Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials",
      "journal": "Nature Reviews Clinical Oncology",
      "year": 2021,
      "citationCount": 9,
      "doi": "10.1038/s41571-021-00503-2",
      "sourceUrl": "https://doi.org/10.1038/s41571-021-00503-2",
      "verified": true
    },
    {
      "title": "Incidence and impact of thromboembolic events in lung cancer patients treated with nivolumab.",
      "journal": "Journal of Clinical Oncology",
      "year": 2017,
      "citationCount": 9,
      "doi": "10.1200/jco.2017.35.15_suppl.e20624",
      "sourceUrl": "https://doi.org/10.1200/jco.2017.35.15_suppl.e20624",
      "verified": true
    },
    {
      "title": "Nonoperative Treatment of Large (5–7 cm), Node-Negative Non–Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines",
      "journal": "Journal of the National Comprehensive Cancer Network",
      "year": 2021,
      "citationCount": 7,
      "doi": "10.6004/jnccn.2021.7043",
      "sourceUrl": "https://doi.org/10.6004/jnccn.2021.7043",
      "verified": true
    },
    {
      "title": "Outcomes of immunomodulatory radiation strategies in combination with nivolumab compared with single agent nivolumab in lung cancer patients.",
      "journal": "Journal of Clinical Oncology",
      "year": 2018,
      "citationCount": 6,
      "doi": "10.1200/jco.2018.36.15_suppl.e21134",
      "sourceUrl": "https://doi.org/10.1200/jco.2018.36.15_suppl.e21134",
      "verified": true
    },
    {
      "title": "6MO: Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)",
      "journal": "Journal of Thoracic Oncology",
      "year": 2025,
      "citationCount": 6,
      "doi": "10.1016/s1556-0864(25)00201-1",
      "sourceUrl": "https://doi.org/10.1016/s1556-0864(25)00201-1",
      "verified": true
    },
    {
      "title": "Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer.",
      "journal": "Journal of Clinical Oncology",
      "year": 2017,
      "citationCount": 6,
      "doi": "10.1200/jco.2017.35.15_suppl.e20665",
      "sourceUrl": "https://doi.org/10.1200/jco.2017.35.15_suppl.e20665",
      "verified": true
    },
    {
      "title": "Abstract 4997: Responsiveness to immune checkpoint inhibitors in RET dependent cancers",
      "journal": "Cancer Research",
      "year": 2019,
      "citationCount": 4,
      "doi": "10.1158/1538-7445.am2019-4997",
      "sourceUrl": "https://doi.org/10.1158/1538-7445.am2019-4997",
      "verified": true
    },
    {
      "title": "Abstract LB281: Mechanisms of resistance to the RAS(ON) multi-selective inhibitor daraxonrasib (RMC-6236) in RAS mutant PDAC and potential resolution with RAS(ON) combination therapies",
      "journal": "Cancer Research",
      "year": 2025,
      "citationCount": 4,
      "doi": "10.1158/1538-7445.am2025-lb281",
      "sourceUrl": "https://doi.org/10.1158/1538-7445.am2025-lb281",
      "verified": true
    },
    {
      "title": "Increasing Impact of Mobile Health Programs: SAHELI for Maternal and Child Care",
      "journal": "Proceedings of the AAAI Conference on Artificial Intelligence",
      "year": 2023,
      "citationCount": 4,
      "doi": "10.1609/aaai.v37i13.26849",
      "sourceUrl": "https://doi.org/10.1609/aaai.v37i13.26849",
      "verified": true
    },
    {
      "title": "Scalable Decision-Focused Learning in Restless Multi-Armed Bandits with Application to Maternal and Child Health",
      "journal": "Proceedings of the AAAI Conference on Artificial Intelligence",
      "year": 2023,
      "citationCount": 3,
      "doi": "10.1609/aaai.v37i10.26431",
      "sourceUrl": "https://doi.org/10.1609/aaai.v37i10.26431",
      "verified": true
    },
    {
      "title": "Assessment of ideal serum dilution for screening of antinuclear antibodies by an indirect immunofluorescence method in diagnosis of autoimmune disorders",
      "journal": "Medical Journal Armed Forces India",
      "year": 2020,
      "citationCount": 3,
      "doi": "10.1016/j.mjafi.2020.03.008",
      "sourceUrl": "https://doi.org/10.1016/j.mjafi.2020.03.008",
      "verified": true
    },
    {
      "title": "PS01.64: Effect of Anti-PD1 Therapy on the Incidence of Thromboembolic Events in Lung Cancer",
      "journal": "Journal of Thoracic Oncology",
      "year": 2016,
      "citationCount": 3,
      "doi": "10.1016/j.jtho.2016.09.099",
      "sourceUrl": "https://doi.org/10.1016/j.jtho.2016.09.099",
      "verified": true
    },
    {
      "title": "Scalable Decision-Focused Learning in Restless Multi-Armed Bandits with Application to Maternal and Child Health",
      "journal": "arXiv (Cornell University)",
      "year": 2022,
      "citationCount": 3,
      "doi": "10.48550/arxiv.2202.00916",
      "sourceUrl": "https://doi.org/10.48550/arxiv.2202.00916",
      "verified": true
    },
    {
      "title": "Osimertinib for Leptomeningeal Disease in EGFR-Mutated NSCLC",
      "journal": "Journal of Thoracic Oncology",
      "year": 2020,
      "citationCount": 3,
      "doi": "10.1016/j.jtho.2020.08.016",
      "sourceUrl": "https://doi.org/10.1016/j.jtho.2020.08.016",
      "verified": true
    },
    {
      "title": "RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma",
      "journal": "Cancer Immunology Research",
      "year": 2025,
      "citationCount": 2,
      "doi": "10.1158/2326-6066.cir-25-0744",
      "sourceUrl": "https://doi.org/10.1158/2326-6066.cir-25-0744",
      "verified": true
    },
    {
      "title": "Expanding impact of mobile health programs: SAHELI for maternal and child care",
      "journal": "AI Magazine",
      "year": 2023,
      "citationCount": 2,
      "doi": "10.1002/aaai.12126",
      "sourceUrl": "https://doi.org/10.1002/aaai.12126",
      "verified": true
    },
    {
      "title": "Abstract 4997: Responsiveness to immune checkpoint inhibitors in RET dependent cancers",
      "journal": "Immunology",
      "year": 2019,
      "citationCount": 2,
      "doi": "10.1158/1538-7445.sabcs18-4997",
      "sourceUrl": "https://doi.org/10.1158/1538-7445.sabcs18-4997",
      "verified": true
    },
    {
      "title": "OA03.05 Tocilizumab for the Management of Immune Mediated Adverse Events Secondary to PD-1 Blockade: Overall Survival Analysis",
      "journal": "Journal of Thoracic Oncology",
      "year": 2017,
      "citationCount": 2,
      "doi": "10.1016/j.jtho.2017.09.017",
      "sourceUrl": "https://doi.org/10.1016/j.jtho.2017.09.017",
      "verified": true
    },
    {
      "title": "Management of acquired resistance to ALK inhibitors: repeat biopsy to characterize mechanisms of resistance significantly impacts clinical outcomes",
      "journal": "Precision Cancer Medicine",
      "year": 2021,
      "citationCount": 2,
      "doi": "10.21037/pcm-21-5",
      "sourceUrl": "https://doi.org/10.21037/pcm-21-5",
      "verified": true
    },
    {
      "title": "Improving Health Information Access in the World’s Largest Maternal Mobile Health Program via Bandit Algorithms",
      "journal": "Proceedings of the AAAI Conference on Artificial Intelligence",
      "year": 2024,
      "citationCount": 1,
      "doi": "10.1609/aaai.v38i21.30329",
      "sourceUrl": "https://doi.org/10.1609/aaai.v38i21.30329",
      "verified": true
    },
    {
      "title": "Outcomes of ERCC1 high locally advanced esophageal cancer patients treated with non-platinum vs platinum based CRT.",
      "journal": "Journal of Clinical Oncology",
      "year": 2017,
      "citationCount": 1,
      "doi": "10.1200/jco.2017.35.4_suppl.192",
      "sourceUrl": "https://doi.org/10.1200/jco.2017.35.4_suppl.192",
      "verified": true
    },
    {
      "title": "Incidence and characterization of venous thromboembolic events (VTE) in patients with pancreatic cancer: Effect of timing of VTE on survival.",
      "journal": "Journal of Clinical Oncology",
      "year": 2012,
      "citationCount": 1,
      "doi": "10.1200/jco.2012.30.15_suppl.4037",
      "sourceUrl": "https://doi.org/10.1200/jco.2012.30.15_suppl.4037",
      "verified": true
    },
    {
      "title": "Survival is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving it Concurrently or After",
      "journal": "International Journal of Radiation Oncology*Biology*Physics",
      "year": 2020,
      "citationCount": 1,
      "doi": "10.1016/j.ijrobp.2020.07.1377",
      "sourceUrl": "https://doi.org/10.1016/j.ijrobp.2020.07.1377",
      "verified": true
    },
    {
      "title": "Figure S5 from RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma",
      "journal": "Unknown Journal",
      "year": 2026,
      "citationCount": 0,
      "doi": "10.1158/2326-6066.31028321",
      "sourceUrl": "https://doi.org/10.1158/2326-6066.31028321",
      "verified": true
    },
    {
      "title": "Mass spectrometry–based approaches for the identification of molecular mechanism of action of ayurvedic medicines in Parkinson disease",
      "journal": "Elsevier eBooks",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/b978-0-443-19084-1.00007-7",
      "sourceUrl": "https://doi.org/10.1016/b978-0-443-19084-1.00007-7",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5040118284",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/bd/AparnaAtFilmFareAward.jpg/330px-AparnaAtFilmFareAward.jpg"
}